BAM-15

BAM-15 is a small-molecule mitochondrial protonophore (uncoupler) that selectively depolarizes the inner mitochondrial membrane without affecting the plasma membrane potential. First described by Kenwood et al. (2014), BAM-15 transports protons across the inner mitochondrial membrane, dissipating the proton gradient that drives ATP synthesis and converting the energy into heat. Unlike classical uncouplers such as FCCP and DNP, BAM-15 has been characterized as having a wider therapeutic window and does not depolarize the plasma membrane at effective mitochondrial uncoupling concentrations. This selectivity makes it a preferred research tool for studying mitochondrial bioenergetics without confounding effects on cellular membrane potential. BAM-15 has been investigated in preclinical models of metabolic dysfunction and oxidative stress.

BAM-15 has been investigated for its activity as a selective mitochondrial protonophore. Researchers observed that BAM-15 inserts into the inner mitochondrial membrane and facilitates proton translocation from the intermembrane space to the mitochondrial matrix, bypassing ATP synthase (Complex V). This uncoupling of oxidative phosphorylation dissipates the proton motive force as heat rather than ATP production, increasing substrate oxidation rates. Studies suggest that BAM-15 reduces mitochondrial membrane potential and reactive oxygen species (ROS) production in cellular models, as the electron transport chain operates at higher flux to compensate for the proton leak. In preclinical metabolic models, researchers observed that BAM-15 administration was associated with increased oxygen consumption, fatty acid oxidation, and energy expenditure. Importantly, BAM-15 does not affect plasma membrane potential at concentrations that fully uncouple mitochondria, distinguishing it from classical protonophores.

Discovery and Characterization

Kenwood et al. (2014) identified and characterized BAM-15 as a mitochondria-selective protonophore. Using fluorescent mitochondrial and plasma membrane potential indicators, researchers demonstrated that BAM-15 uncouples mitochondria without depolarizing the plasma membrane, unlike FCCP, which affects both [1].

Metabolic Effects In Vivo

Alexopoulos et al. (2020) investigated BAM-15 in diet-induced obese mice. Researchers observed that oral BAM-15 administration was associated with reduced fat mass, improved insulin sensitivity, and decreased hepatic lipid accumulation without affecting food intake or lean body mass [2].

ROS Reduction

Geisler et al. (2019) investigated the effects of BAM-15 on mitochondrial ROS production in hepatocyte models. The researchers observed that mild uncoupling with BAM-15 was associated with decreased superoxide production from Complex I and Complex III of the electron transport chain [3].